The stage of laryngeal cancer before and after the COVID-19 pandemic: A retrospective study
Advances in Clinical and Experimental Medicine · 2026
DOI: 10.17219/acem/205234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2026. Verfasst von Joanna Cieślik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Cracow, Poland. Hauptthemen laut MEDLINE: COVID-19, Laryngeal Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: The COVID-19 pandemic severely restricted global access to healthcare, including for patients with laryngeal cancer (LC). OBJECTIVES: To compare laryngeal cancer stage distribution (TNM classification), surgical treatment patterns (types of surgery and perioperative complications), and timelines before vs 1 year after the COVID-19 pandemic declaration. MATERIAL AND METHODS: We conducted a retrospective, single-center, cross-sectional study at a tertiary care center in Poland. The analysis included 110 patients hospitalized for laryngeal cancer during 2 six-month intervals: October 2019-March 2020 (prepandemic, group 1) and October 2021-March 2022 (post-pandemic, group 2). RESULTS: Group 1 included 49 patients, and group 2 included 61. Baseline characteristics were similar between groups, with males comprising 96.9% of group 1 and 83.6% of group 2. Admissions via the fast-track cancer pathway increased from 33.3% in group 1 to 52.5% in group 2. Although a higher proportion of patients in group 2 were classified as stage IVB by TNM, the difference was not statistically significant. Surgical treatment patterns were largely consistent across groups, except for a decrease in total laryngectomy from 18.4% in group 1 to 3.3% in group 2. Moderately differentiated tumors (G2) were more common in group 1 (66.7%) than in group 2 (35%). High concordance was observed between clinical and pathological staging for tumor size (79.1%) and regional lymph node metastasis (87.5%). CONCLUSIONS: Future research should extend the post-COVID-19 observation period, as pandemic-related adverse effects on cancer diagnosis and outcomes may not fully manifest until several years later.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Cracow, Poland.
- Department of Otolaryngology and Oncological Surgery of the Head and Neck, 5th Military Hospital with Polyclinic, Cracow, Poland.
- Department of Otolaryngology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Zitieren
APA
Cieślik, J., & Tomik, J. (2026). The stage of laryngeal cancer before and after the COVID-19 pandemic: A retrospective study. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/205234
Vancouver
Cieślik J, Tomik J. The stage of laryngeal cancer before and after the COVID-19 pandemic: A retrospective study. Advances in Clinical and Experimental Medicine. 2026. doi:10.17219/acem/205234
BibTeX
@article{Cielik2026,
author = {Cieślik, Joanna and Tomik, Jerzy},
title = {The stage of laryngeal cancer before and after the COVID-19 pandemic: A retrospective study},
journal = {Advances in Clinical and Experimental Medicine},
year = {2026},
doi = {10.17219/acem/205234}
}
EUVIMED